The Tan Sheet

Home

Opinion

The Tan Sheet

"The Tan Sheet" provides in-depth coverage of news related to nonprescription pharmaceuticals and dietary supplements.

January 14, 2013

January 14, 2013 by Donald Riker, PhD

Chattem To Revive Rolaids Line Bought From J&J

"Don Riker, president of On Point Advisors...expects the claims war between [Tums & Rolaids] to be centered on their acid neutralization stories, speed of relief and the presence or absence of magnesium hydroxide, which has a laxative effect, some would say to counteract the constipating effect of calcium carbonate."

click to read

December 17, 2012

December 17, 2012 by Donald Riker, PhD

Medagate Turns OTC Purchases Into Data For Manufacturers, Insurers

" 'The process shifts costs from insurers to consumers... additionally, insurers likely will learn something about consumers' health care habits from the sales data. Many first-line treatments have moved OTC - they need a handle on that', Riker said"

click to read

September 24, 2012

September 28, 2012 by Donald Riker, PhD

Matrixx Rejected On ProPhase Labs Bid

" 'I think it's a smart move on Matrixx's part --- they gain control of the niche, more shelf space, merchandizing space, they gain clinical trials and data that might be useful to support both cold lines,' said Don Riker, president of consumer health products consultancy On Point Advisors... 'Whatever their motives, if you add all that up, they might see it as an inexpensive way to capture that [pipeline] without the risk', Riker said."

click to read

June 25, 2012

June 26, 2012 by Donald Riker, PhD

"OTC brand consultant Donald Riker said the combination of being linked to the NyQuil brand and having a single-ingredient formulation could position ZzzQuil well in the marketplace...the whole point of Nyquil was to relieve symptoms so you could rest, but now P&G is trying to shoehorn NyQuil into a narrower sleep-aid positioning, Riker said...the real competition is Advil PM and Tylenol PM..."

click to read

September 20, 2010

September 25, 2010 by Donald Riker, PhD

J&J Recalled To Capitol Hill As Besieged Consumer Group Chair Retires

"Goggin's looming departure is a necessary step in the firm's "cleansing process", and Weldon could be next to move on, said Don Riker, President of consumer health products consultancy On Point Advisors"

click to read

Jan 4, 2010

May 27, 2010 by Administrator

“Sanofi-Aventis' $1.9 billion bid for OTC and personal care product firm Chattem offers the French firm a coveted toehold in the sizeable U.S. consumer health care market while also opening potential opportunities in emerging markets…”

click to read

Oct 5, 2009

May 25, 2010 by Administrator

“Lawsuits alleging that zinc in two popular denture creams damages nerves, combined with the recent recall of some zinc-containing Zicam products, could call into question the use of the mineral, which trade groups insist is safe when taken appropriately…”

click to read

Aug 31, 2009

May 25, 2010 by Administrator

“FDA's announcement it is investigating a possible risk of liver injury related to orlistat - the active ingredient in Roche Pharmaceuticals' prescription weight-loss drug Xenical and GlaxoSmithKline's OTC Alli - could threaten short-term sales…”

click to read

Jan 4, 2010

May 18, 2010 by Administrator

“Sanofi-Aventis will need to build an infrastructure geared to Rx-to-OTC switch in order to make a successful U.S. consumer business out of its planned acquisition of Chattem and become established as a switch player…”

click to read

The Deal provides unique and proprietary content that serves the news, information, and idea generation needs of corporate and financial dealmakers.

Password
Not a Member? Register \| Lost Password or Username?

Username
	Remember Me

The Tan Sheet

Sign up for our Email Alerts

More opinions

More insights